Symrise wins €125m EIB loan for nutrition and skin R&D
The European Investment Bank money was important for ongoing projects of the German flavours and fragrance that has made big steps toward nutritional projects in recent years including investments in probiotics by way of example.
“Research and development is the foundation of our innovative strength and the basis for our accelerated growth,” said Symrise CEO Dr Heinz-Jürgen Bertram.
“For many years, Symrise has invested heavily in the research of innovative fragrances, flavors and functional ingredients, as well as into the development of environmentally friendly technologies and new process techniques.”
“We are delighted that the European Investment Bank is supporting us in this area as a financing partner with a long-term perspective. This recognises our activities and gives us an incentive to continue along our high standards of innovation, quality and consumer awareness.”
The work will occur in its Life Essentials and Consumer Health business units. Symrise employs more than 100 people in R&D.
Symrise recently bought a 15% stake in Swedish probiotics supplier Probi and the two companies are working on oral and other products in that area.
It had a turnover of €1.6bn in 2011.
